Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Outpatient"


25 mentions found


Wall Street is underestimating the opportunity for a cardiovascular medical device company's core product to penetrate the market, according to Morgan Stanley. Analyst Patrick Wood upgraded shares of Shockwave Medical to overweight from in-line, saying the Street is misjudging the potential catalysts that could improve the sales outlook for its coronary IVL catheter used before stent implantation, and that consensus expectations look "too low." Given this setup, Wood lifted his price target to $335 a share, reflecting 28% upside from Friday's close. SWAV YTD mountain Share performance in 2023 Potential catalysts for Shockwave shares include an investor day, a favorable environment for medical technology and an extended timeline before it faces new competition, Wood said. "We think recent coronary reimbursement improvements from CMS mean the market is underestimating the penetration opportunity over the coming 2-3 years," Wood wrote.
Persons: Morgan Stanley, Patrick Wood, Wood, — CNBC's Michael Bloom Organizations: Shockwave, Centers, Medicare, Medicaid
An exterior view of the Advance Auto Parts store at the Sunbury Plaza. Check out the companies making the biggest moves before the bell:Advance Auto Parts — Advance Auto Parts declined 2.4% in the premarket after Atlantic Equities on Monday downgraded the stock to underweight, and cut its price target to $50. Meta Platforms — Shares of the social media company rose about 1% in premarket trading. Fisker — The electric vehicle maker's stock rose less than 1% after the company announced a $340 million convertible note offering, with the potential to increase it to $680 million. Charles Schwab — Shares of the brokerage firm rose 1.9% in premarket trading after JMP upgraded Schwab to market outperform from market perform.
Persons: Sam Hudson, Carl Icahn, Mark Zuckerberg, Fisker, Charles Schwab —, JMP, Schwab, Morgan Stanley, Yun Li, Sarah Min, Jesse Pound Organizations: Advance, Journal, Shockwave Locations: Sunbury
Here's a deeper look at the headlines and their implications for our investment theses in these two health-care companies. The Club's take: The first-of-their-kind FDA and CMS actions came in generally as anticipated, and represent incremental positives for Eli Lilly. That's why some of the decline seen Friday in Eli Lilly shares – down over 2%, to around $453 each – could simply represent a sell-the-news situation. Eli Lilly has said donanemab could be approved by the FDA late this year or in early 2024. Our expectations around donanemab sales also are measured, and the drug is not the primary driver of our multiyear optimism for Eli Lilly.
Persons: Eli Lilly, Eli Lilly's donanemab, Leqembi —, Biogen, , Lilly's, That's, Donanemab, Lilly, donanemab, that's, Lisa Gill, UnitedHealth, Humana, Gill, What's, We'll, Jim Cramer's, Jim Cramer, Jim Organizations: Club, Drug Administration, Medicare, Medicaid Services, FDA, GE Healthcare, Humana, JPMorgan, CNBC Locations: Massachusetts
The S & P 500 rose 8.3% in the second quarter to extended its 2023 advance to 15.9%. Here's a closer look at the Club's best and worst performers in the first half of 2023, starting with the four winningest stocks. West Texas Intermediate crude ended the second quarter under $71 per barrel, about $10 below where it started the year. Humana (HUM) dropped 12.7% in the first half of 2023, rounding out the bottom-four Club stocks between January and June. The common denominator among the worst-performing Club stocks is a bit less obvious than with the winners.
Persons: It's, Dow, Here's, Mark Zuckerberg, Palo, Lisa Su, , Eli Lilly, Locker, Foot Locker's, Estee Lauder, Estee, Halliburton haven't, encouragingly, Halliburton, Jim Cramer's, Jim Cramer, Jim, Jen, Hsun Huang, Huang, Andrej Sokolow Organizations: Nasdaq, Dow Jones, Nvidia, FactSet, Meta, Investors, Facebook, Networks, Palo Alto Networks, Alto, AMD, Devices, Palo, would've, The, HAL, Halliburton, West Texas, Coterra, Humana, Disney, DIS, CNBC, Consumer, Audi, Getty Locations: China, Meta, Palo, Palo Alto, Las Vegas, USA
New York CNN —Companies are sitting on a lot less cash than they were last year, largely because they’re spending it on share buybacks and corporate dividends. What’s happening: A new report from Moody’s Investors Service finds that nonfinancial companies’ corporate cash declined 12% last year to $2 trillion. But debt was flat year over year, meaning that companies didn’t use much of their cash reserves to pay down outstanding loans. Now that it’s more expensive to borrow, companies in the US should reconsider the amount of money they’re spending on buybacks, he added. Preventing companies from repurchasing their own shares, they argue, would free corporate cash to invest in growth and raise wages instead.
Persons: Emile El Nems, , Ben Lofthouse, Janus Henderson, ” El Nems, Joe Biden, buybacks, , Brian Moynihan, Moynihan, CNN’s Poppy Harlow, Nathaniel Meyersohn, That’s Organizations: CNN Business, Bell, New York CNN — Companies, Moody’s Investors Service, Moody’s, Federal Reserve, Bank of America, Corporations, , CNN, Commerce Department, UBS Locations: New York, buybacks
They estimate that up to $500 million of medical costs in 2023 will be attributable to pickleball. A UBS analyst note estimated pickleball, which has been likened to a combination of tennis and ping pong, would be responsible for $250 million to $500 million of medical costs in 2023. One reason for the high medical costs associated with pickleball is the sport's demographic. The Sports & Fitness Industry Association's report estimated there were 8.9 million pickleball players above the age of six in the US; the Association of Pickleball Professionals estimated in January that there were 36.5 million pickleball players in the US. The UBS analysis estimated there would be 22.3 million pickleball players in the US this year.
Persons: pickleball Organizations: UBS, Morning, Fitness Industry Association, Fitness Industry, Association of Pickleball Professionals, Google Locations: pickleball
The rapidly aging population is expected to be a boon for senior housing. About 50% of those in assisted living facilities, for example, are aged 85 and older, while 31% are between 75 and 84 years old, according to the National Center for Assisted Living . Bumpy road but 'attractive valuation' ahead Right now, senior housing is seeing favorable demographics, as well as improving fundamentals and margins, said NIC's Clapp. There's a point where for each incremental bed added in senior housing, you might not need another worker in the building, he explained. Other names tied to the trend include Ensign and Omega Healthcare Investors , which both provide skilled nursing and senior living services, as well as Brookdale Senior Living , an operator of senior living communities with just a $755 million market cap.
Persons: Wells, Connor Siversky, Welltower, Ventas, Raymond James, Jonathan Hughes, You've, they've, Caroline Clapp, Greg Kuhl, Janus Henderson, We've, we've, Kuhl, Siversky, NIC's Clapp, Clapp, there's, Stocks, Janus Henderson's Kuhl, that's, Hughes, CNBC's Michael Bloom Organizations: . Census, National Center for, National Investment Center, Seniors Housing, Care, U.S . Census Bureau, NIC, Investors, Estate Fund, Omega Healthcare Investors Locations: U.S, NOI
Pickleball injuries may cost Americans $377 million in health care costs this year, accounting for 5% to 10% of total unexpected medical costs, UBS analysts estimated in a report Monday. From 2010-2019, 86% of emergency department visits due to pickleball injuries occurred in people over 60 years old, according to the medical study. Around 60% of pickleball injuries are sprains, strains and fractures. The analysts estimated that there will be around 67,000 emergency room visits, 366,000 outpatient visits and 9,000 outpatient surgeries related to pickleball injuries this year. According to the Sports and Fitness Industry Association trade group, pickleball has grown from 3.5 million players in 2019 to 8.9 million in 2022.
Persons: New York CNN —, Pickleball Organizations: New, New York CNN, UBS, Sports, Fitness Industry Association Locations: New York
A sport that is making many older Americans more active could be backfiring for health insurance companies, according to UBS. Pickleball is a tennis-adjacent sport that has exploded in popularity since the Covid-19 pandemic, attracting millions of new players and celebrity investors . "After analyzing the growth in pickleball as well as the nature and frequency of related injuries, we conducted a bottom-up analysis of medical costs. In total, we estimate $250-500 mn of medical costs directly attributable to pickleball and see potential for greater medical costs indirectly linked to pickleball," the note said. All said, we estimate that pickleball medical costs could be driving 5-10% of the unexpected medical cost trend this year," the note said.
Persons: Andrew Mok, Goldman Sachs, Mok, UNH, — CNBC's Michael Bloom Organizations: UBS, Pickleball, Insurance, Medicare Locations: pickleball, UnitedHealth, Friday's
Vaccinating one million adults ages 65 and above with a single RSV shot from Pfizer or GSK may prevent thousands of hospitalizations over two seasons of the virus, according to a Centers for Disease Control and Prevention analysis. The committee recommended that adults ages 60 and older may receive one dose of Pfizer's or GSK's respiratory syncytial virus shot after consulting their doctor. The analysis also found that vaccinating one million adults in the same age group with one dose of GSK's shot may prevent roughly 2,300 hospitalizations and 23,000 outpatient visits. Each year, RSV hospitalizes 60,000 to 160,000 older adults and kills 6,000 to 10,000, according to CDC data. Last year, cases of RSV – along with Covid and the flu – in children and older adults overwhelmed hospitals across the nation.
Persons: Michael Melgar Organizations: Pfizer, GSK, Centers for Disease Control, University of Michigan, Northern Hemisphere
Pfizer 's vaccine that protects adults ages 60 and older from respiratory syncytial virus was slightly less effective after 18 months, according to clinical trial results the company announced Wednesday. The data is from New York-based Pfizer's clinical trial on more than 34,000 older adults over two RSV seasons, or 24 months. The vaccine was roughly 49% effective against the same condition with two or more symptoms after 18 months, according to Pfizer. Anderson said studies are ongoing, and so is research evaluating the shot's efficacy in older adults with weak immune systems. RSV kills 6,000 to 10,000 older adults and hospitalizes 60,000 to 160,000 of them every year, according to the CDC.
Persons: Pfizer's, It's, Annaliesa Anderson, Anderson, Pfizer hasn't Organizations: Pfizer, Northern, That's, Centers for Disease Control, and Drug Administration, GlaxoSmithKline, CNBC, CDC Locations: New York, U.S
Top 10 things to watch in the stock market Tuesday
  + stars: | 2023-06-20 | by ( Jeff Marks | ) www.cnbc.com   time to read: +3 min
It's a new week but the recent stock market rally makes for a not-so-great set up as Jim Cramer told the Investing Club Monday evening in his weekly column. Jim and "Mad Money" are in Detroit for all things Ford (F) with CEO Jim Farley, covering everything from Ford Blue to Ford Pro to Ford Model e (electric vehicles). Bank of America adds Club stock Amazon (AMZN) to its US 1 list. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB.
Persons: Jim Cramer, Dow, Jim, Jim Farley, They'll, Elon Musk, Sartorius, Cowen, Eli Lilly, Raymond James, Morgan Stanley, Philip Morris, Jim Cramer's Organizations: Nasdaq, Ford, Ford Pro, Ford Model, Elon, Bank of America, Nvidia, Club, Dice Therapeutics, Avis Budget, Citi, Delta Air Lines, DAL, PayPal, Nike, Dow, Barclays, Jim Cramer's Charitable, CNBC Locations: Detroit
June 16 (Reuters) - Health insurer Humana Inc (HUM.N) joined larger rival UnitedHealth (UNH.N) in warning of a jump in medical costs this year due to higher-than-expected demand for surgeries and other medical procedures. Humana on Friday also pointed to elevated demand for outpatient surgeries and dental services, as well as strong inpatient demand in recent weeks, a trend it said was diverging from historical seasonality patterns. The health insurer generated more than 80% of its premiums and services revenue in 2022 from offering government-backed Medicare plans. UnitedHealth had flagged higher costs earlier this week following an increase in surgeries among older adults, wiping out billions in the market capitalization of health insurers including Humana. On the flip side, the rise in medical procedures is expected to help hospital operators and medical device makers, especially those in the orthopedic space.
Persons: UnitedHealth, Leroy Leo, Anil D'Silva Organizations: Humana Inc, Humana, Thomson Locations: Bengaluru
iRobot — The stock surged 19% after U.K. regulators approved Amazon's $1.7 billion acquisition of the Roomba vacuum cleaner maker. Cava Group — Cava Group shares dropped 15% during trading Friday, giving back some of its gains from its massive debut Thursday on the New York Stock Exchange. SoFi Technologies — The financial technology stock dropped more than 8% after both Bank of America and Piper Sandler downgraded it to neutral from buy, citing SoFi's recent run higher. Micron Technology — Shares dipped 1.5% after Micron Technology said a China chip ban could hurt the company. Truist Financial — Shares fell 1.6% after Odeon Capital Group downgraded Truist Financial to hold from buy, according to FactSet.
Persons: Richard Branson, iRobot, Piper Sandler, Refinitiv, Morgan Stanley, Joseph Moore, — CNBC's Michelle Fox, Alex Harring, Yun Li Organizations: Virgin Galactic —, West Pharmaceutical Services, Bank of America, — Cava, New York Stock Exchange, Technologies, Adobe, Nvidia, Devices, Micron Technology, U.S . Securities, Exchange Commission, — Humana, Odeon Capital Locations: China
A warning from UnitedHealth Group executives Wednesday that demand for medical services was rising sent insurance stocks tumbling and, in turn, hit investors who bet on health care. The biggest health-care exchange-traded fund, the $41 billion Health Care Select Sector SPDR Fund (XLV) , lost 1% Wednesday. The $17 billion Vanguard Health Care ETF (VHT) also fell about 1%. XLV 5D mountain The XLV was dragged down by insurance stocks on Wednesday. Some Wall Street analysts said the dramatic sell-off in typically stodgy insurance stocks could prove to be a buying opportunity.
Persons: John Franklin Rex, Rex, that's, Cantor Fitzgerald, Sarah James, — CNBC's Michael Bloom Organizations: UnitedHealth Group, Humana, CVS Health, Health Care, CVS, Devices, Abbott Laboratories
Health insurer stocks dropped on Wednesday after UnitedHealth Group warned of higher medical costs as older Americans start to catch up on surgeries they delayed during the Covid pandemic. Shares of UnitedHealth, the largest U.S. healthcare provider by market value, closed around 6% lower. Elevance Health closed roughly 7% lower, and CVS Health , which owns the insurer Aetna, slid nearly 8%. The company has recorded "strong outpatient care activity" throughout April, May and the early part of June, CFO John Rex said at a Goldman Sachs healthcare conference. Shares of medical device manufacturers Medtronic and Stryker jumped 2.5% and 4%, respectively, after UnitedHealth's remarks.
Persons: UnitedHealth, John Rex, Goldman Sachs, Medicare enrollees, Rex, Timothy Noel, Stryker, UnitedHealth's Organizations: UnitedHealth, Medicare, Humana, Elevance Health, CVS Health, Aetna, Insurance, Goldman, Healthcare, Tenet Healthcare
The warning also dragged down shares of rival health insurers that largely benefited from delayed non-urgent surgeries such as hip and knee replacements and hospital staffing shortages that had further led to fewer procedures. UnitedHealth, at a Goldman Sachs healthcare conference, highlighted elevated demand for outpatient medical procedures, particularly related to knees and hips, from patients in Medicare health plans meant for those aged 65 and above. UnitedHealth also expects its full-year medical loss ratio at the upper end of its forecast. UnitedHealth's 18.51 forward 12-month price-to-earnings ratio - a common benchmark for valuing stocks - is higher than rival Cigna Corp's (CI.N) 10.29 and CVS Health Corp (CVS.N) 8.26. Shares of Humana Inc (HUM.N) fell 7%, while Elevance Health and CVS Health Corp's (CVS.N) fell more than 3% each in premarket trading.
Persons: Goldman Sachs, Tim Noel, UnitedHealth, Julie Utterback, Cigna Corp's, Leroy Leo, Shinjini Organizations: UnitedHealth, Goldman, CVS Health Corp, Humana Inc, Elevance, CVS Health, Thomson Locations: Bengaluru
An insurance exec warned of higher medical costs as Americans start to get more elective procedures. It suggests people are getting care they put off during the height of the pandemic. Older Americans are starting to get more procedures like hip and knee surgeries, and it's driving up how much one of the biggest US health insurers is spending on medical care. The "strong" level of care older Americans are seeking out suggests that people are getting more comfortable getting procedures they put off during the pandemic, the UnitedHealth Group executive said. The stocks of health insurance companies tumbled on Wednesday following the warning.
Persons: John Rex, Goldman, Jodi Jacobson, Stryker, Medtronic Organizations: UnitedHealth, UnitedHealth Group, CVS Health, Tenet Locations: Goldman Sachs, Aetna
REUTERS/Mike Blake/File Photo/File PhotoJune 14 (Reuters) - Health insurer stocks dropped sharply on Wednesday after UnitedHealth Group (UNH.N) said costs were on the rise for the largest U.S. healthcare provider by market value due to an increase in surgeries among older adults. Shares of industry bellwether UnitedHealth fell 7.3% to $455.11, wiping out roughly $42 billion from the company's market capitalization in the current trading session. Meanwhile, stocks of medical device makers and hospital operators rose, as increased frequency of surgeries mean more revenue for them. The company highlighted strong demand for hip and knee procedures at outpatient centers, as well as for home health services and behavioral services. Elevance Health (ELV.N), CVS Health Corp (CVS.N), Centene Corp (CNC.N) and Cigna Group (CI.N) fell between 6% and 7.5%.
Persons: Mike Blake, bellwether, UnitedHealth, Jefferies, Brian Tanquilut, Zimmer Biomet, Leroy Leo, Bhanvi, Manas Mishra, Shinjini Organizations: REUTERS, UnitedHealth, Medicare, Humana Inc, Reuters Graphics, Elevance, CVS Health Corp, Centene Corp, Cigna, Elevance Health Inc, CVS, Healthcare, Tenet Healthcare, Stryker, Thomson Locations: Santa Ana , California, U.S, Bengaluru
Shortly after the opening bell Wednesday, we'll be buying 15 shares of Humana (HUM), at roughly $473 apiece. Following the trade, Jim Cramer's Charitable Trust will own 100 shares of HUM, increasing its weighting in the portfolio to 1.83%, from 1.56%. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB.
Persons: we'll, Jim Cramer's, Johnson, UNH, Jim Cramer, Jim, Owen Franken Organizations: Humana, Johnson, GE Healthcare Technologies, UnitedHealth, CNBC
CNN —It’s only June, but scientists in the US are already thinking about flu season. As always at this time of year, they’re keeping a close eye on Australia, which saw an early start to its flu season. “We closely monitor what happens in countries throughout the Southern Hemisphere this time of year, just to see what’s happening during their flu season. If many people opt out of the flu vaccine, cases could rise. So while Reed and her colleagues will be watching Australia’s flu numbers and running their calculations, it’s still not totally clear what 2023’s flu season will bring for the US.
Persons: CNN — It’s, don’t, Care, It’s, , Carrie Reed, Reed, “ We’ve, Thomas McAndrew, , Taylor Swift, ” McAndrew, William Schaffner, Dr, Sanjay Gupta, , it’s, ” Reed Organizations: CNN, Australian Department of Health, US Centers for Disease Control, CDC, Department of Community, Population Health, Lehigh University . “, Vanderbilt University Medical Center, National Foundation for Infectious Diseases, CNN Health, World Health Organization, agency’s Department of Health, Care Locations: Australia, Southern, Chicago, agency’s
The US military is planning to independently test the quality of generic drugs, Bloomberg reported. The quality of the US drug supply has come into question amid recalls of medications like metformin. The US military is reportedly planning to take extra steps to test the quality of the generic drugs it buys for servicemembers and their families. Bloomberg reported in May that the White House has assembled a team to tackle shortages and quality issues with generic medications. "I have family who take generic drugs, I take generic drugs," he said, adding, "I don't get concerned and I don't tell them to be concerned."
Persons: Anna Edney, Riley Griffin, Valisure, David Light, Jeremy Kahn, Mike Ganio, ASHP Organizations: Bloomberg, FDA, Morning, servicemembers, Department of Defense, White, DOD, Food and Drug Administration, American Society of Health, System
The New York City chapter of the National Alliance on Mental Illness — the country’s largest organization representing the mentally ill and their families — has protested on City Hall’s steps against Mr. Adams’s efforts to loosen standards for mandatory care. It is to say that the drugs shouldn’t be considered — as they tend to be now — the required linchpin of treatment. Science hasn’t made great strides in antipsychotics since the drugs were first introduced seven decades ago. Commonly, people abandon their antipsychotic drugs, whether they’re in mandatory treatment or the most sensitive, attentive voluntary programs. This is generally attributed to anosognosia and the disorganization that can come with mental illness, but it might well be seen as an outcome from the weighing of pros and cons.
Persons: , they’re, that’s, Michelle Funk, shouldn’t, hasn’t, anosognosia Organizations: New, National Alliance, New York, New York City Bar Association, World Health Locations: New York City
Now she rarely works overtime, gets six weeks of paid vacation a year, and got a free master's. In Sweden, if you work late, your boss might flag that your workload is too high, or that you're not capable enough to do your work within work hours. His company sponsored both of our residencies and work visas, so we had the ability to live and work in Sweden full time. I get six weeks of paid vacation every year and I use it allSweden's Annual Leave Act gives workers the legal right to take at least four weeks of consecutive paid vacation between the months of June and August. My company gives us six weeks of paid vacation per year, and I take all of it.
The startup offers both in-person clinical services and software for healthcare providers. We got an exclusive look at the 8-slide deck it used to raise the fresh funds. A startup that combines brick-and-mortar clinical services with software for healthcare providers just raised $108 million in fresh funds despite a drop off in global healthtech funding. While the average dental clinic in Germany operates four to six different software solutions to manage a whole patient journey, Patient21 aims to stand out by consolidating these services into one. With the fresh funds, Patient21 will hone the development of its software platform, and expand from Germany into newer European markets.
Total: 25